Novo Holdings A/S - OPHTHOTECH CORP ownership

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of OPHTHOTECH CORP
ValueSharesWeighting
Q3 2016$166,552,000
-9.6%
3,610,4870.0%14.79%
-23.5%
Q2 2016$184,243,000
-11.2%
3,610,487
-26.5%
19.34%
-15.0%
Q1 2016$207,566,000
-46.2%
4,910,4870.0%22.75%
-38.6%
Q4 2015$385,621,000
+93.8%
4,910,4870.0%37.06%
+80.3%
Q3 2015$198,973,000
-22.2%
4,910,4870.0%20.56%
+11.8%
Q2 2015$255,640,000
+11.9%
4,910,4870.0%18.38%
-5.4%
Q1 2015$228,485,000
-13.7%
4,910,487
-16.8%
19.43%
-9.3%
Q4 2014$264,815,000
-1.4%
5,901,819
-14.4%
21.42%
-18.2%
Q3 2014$268,493,000
-54.0%
6,896,819
-50.0%
26.18%
-10.5%
Q2 2014$584,187,000
+18.6%
13,807,3080.0%29.24%
-4.9%
Q1 2014$492,541,000
+10.3%
13,807,3080.0%30.74%
-7.8%
Q4 2013$446,666,00013,807,30833.33%
Other shareholders
OPHTHOTECH CORP shareholders Q3 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 1,103,981$44,734,00025.02%
Novo Holdings A/S 4,910,487$198,973,00020.56%
JHL Capital Group LLC 3,265,000$132,298,00014.62%
AlpInvest Partners B.V. 111,519$4,519,0008.90%
Opaleye Management Inc. 105,000$4,255,0002.09%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 16,110$653,0002.05%
IMA Wealth, Inc. 66,061$2,623,0001.66%
WILLIAM HARRIS INVESTORS INC 143,022$5,795,0001.64%
Orbimed Advisors 1,923,500$77,940,0000.79%
Overbrook Management Corp 117,807$4,774,0000.74%
View complete list of OPHTHOTECH CORP shareholders